Dare Bioscience, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2024-11-22: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2024-10-21; Total offering amount $15,000,000.
- 2021-09-07: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-11-20; Total offering amount $3,544,992.
- 2019-12-06: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-11-20; Total offering amount $2,369,992.
- 2012-12-14: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2012-11-30; Total offering amount $13,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2024-11-22 | Rule 506(b) | Equity | 2024-10-21 | $15,000,000 | $0 | $15,000,000 | 1 |
| 2021-09-07 D/A | Rule 506(b) | Equity | 2019-11-20 | $3,544,992 | $3,544,992 | $0 | 28 |
| 2019-12-06 | Rule 506(b) | Equity | 2019-11-20 | $2,369,992 | $2,369,992 | $0 | 28 |
| 2012-12-14 | Rule 506 | Equity | 2012-11-30 | $13,000,000 | $13,000,000 | $0 | 16 |
| 2010-11-19 | Rule 506 | Equity | 2010-11-12 | $23,999,989 | $16,499,994 | $7,499,995 | 17 |
| 2009-07-27 | Rule 506 | Equity | 2009-07-13 | $10,000,000 | $10,000,000 | $0 | 13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |